Websites for pharma companies corporate sites, catalogues, export portals

Why Mumbai pharma companies are rebuilding their websites

The Mumbai pharma belt is a strange place online. Corporate offices along Chakala and the Andheri-Kurla Road stretch run export operations into dozens of countries. Units in MIDC Andheri and Taloja make APIs and formulations that clear audits from buyers who fly in from three continents. The Tarapur MIDC belt at Boisar ships worldwide. And then you open their websites. A homepage from 2012. A products page that says coming soon. A catalogue that only exists as a PDF someone emails around.

That gap costs enquiries every day, and it's why searches for a pharmaceutical website design company in Mumbai keep climbing. The people who decide whether to work with you now check you online first. An importer shortlisting suppliers for a tender. A brand owner hunting third party manufacturing for a new range. A stockist deciding which company's products to push. Even a QA candidate deciding whether your opening is worth leaving a stable job for. Every one of them lands on your website before they pick up the phone. If the site looks abandoned, most never do.

There's a second problem: middlemen have filled the space. Search a molecule plus India and the first page is directories and listing portals, not manufacturers. Buyers wade through commission agents to find the actual plant. A proper catalogue site flips that. Your product pages get indexed, molecule searches land on you, and the enquiry arrives in your inbox instead of a marketplace that resells it.

Who your website actually has to convince

Not one audience. Four.

• Export buyers and importers checking your dosage forms, markets and plant approvals before they shortlist you.
• Brands hunting a third party manufacturer, comparing capabilities and minimums across five or six sites in an afternoon.
• Distributors and stockists who want a rate list, availability, and an easy way to order or apply for a territory.
• And for OTC and nutraceutical lines, direct customers who can legally buy online, if you give them a store.

A generic template serves none of them well. Pharma buying is structured, so the site has to be structured the same way. Here's roughly what that costs.

What a pharma website has to do differently

Most agencies treat a pharma site like any business site with a medical colour scheme. That's how you end up with a pretty brochure that generates nothing. Three things separate a working pharma website from a decorated one.

Product pages that respect the rules

Plenty of belt companies keep their site thin out of fear. Someone in the office heard you can't talk about medicines online, so the products page stays empty. The reality is narrower. The Drugs and Magic Remedies (Objectionable Advertisements) Act restricts consumer-facing promotional claims, especially cure claims for scheduled conditions. It does not stop you from presenting your business and what you make as facts. Composition. Strength. Dosage form. Pack style. Therapeutic segment. That factual record is exactly what a B2B buyer needs to shortlist you.

So we build product pages as capability records, not advertisements. Prescription products get factual pages with no consumer claims. OTC and nutraceutical lines get marketing-forward pages and, where you want it, a checkout. And your regulatory team keeps the final word: every product page goes through your sign-off before it's live. We make that review easy. We don't replace it.

A catalogue buyers can actually use

A pharma catalogue is not twelve product photos on one page. It's search by molecule, brand and therapeutic segment. Filters for dosage form. A downloadable product list for buyers who work in Excel. Market availability flags for exporters. And every product as its own indexed page, so when someone searches a molecule with manufacturer India, the result is you, not a directory. For product businesses, the catalogue is the core of our web development scope, and it's the piece that pays back first.

Enquiry flows that qualify, not just collect

A plain contact form is where enquiries go to die. A third party manufacturing form should ask dosage form, quantity, target market and timelines. An export form should ask country and registration status. A distributor application should ask territory and current lines. Structured forms do two jobs: serious buyers self-qualify, and your team gets an alert on WhatsApp and email with everything needed to reply properly in the first message. Speed matters more than polish here. The company that replies first, with real answers, usually wins the enquiry.

Process, timeline and what affects cost

People search pharma website design cost India, and even pharma website ka price, and find either ₹6,000 marketplace listings or agencies hiding numbers behind a call. Both waste your time. Here's how it works with us.

How we work

First, a free scoping call. You tell us what you make, who buys it and what the site should do. We come back with a site map and a fixed quote, usually within 3 to 4 days. Then content collection starts, and this is the honest bottleneck on every pharma build: product data, certificates, plant photos, clean English copy. We give you a checklist and chase it with you. Design gets signed off before development starts. Your team, including whoever handles regulatory review, checks every product page before launch. Then go-live, training for whoever will maintain the catalogue, and support after. No surprise invoices mid-project. And no abandoned builds: in 15 years we've never walked away from one.

What moves the price

Five things, roughly in order. Product count and how clean your product data is. Portals, because a distributor login with rate lists and ordering costs more than an enquiry form. Ecommerce for OTC or nutraceutical lines, with payments and shipping. Languages, if your export markets need more than English. And integrations.

On integrations: most belt companies already run Marg or Tally plus some distribution software, and half the fear of a new website is that it will fight those systems. It won't. We sync order portals and enquiry flows into what you already run, so nothing gets re-typed. If you want to go further, we build small operational tools alongside the site: batch and expiry aware stock views for what's listed online, order status pages for distributors. Tools that sit next to your existing setup. We don't replace your ERP or your QMS, and we don't touch your compliance systems; they stay exactly where your auditors expect them. For deeper operational software on the Taloja side, that's a separate conversation, covered on our custom software page for Navi Mumbai.

What do belt companies usually pick? A Chakala marketing office rebuilds the corporate site plus catalogue. A Tarapur exporter adds capability pages and an export enquiry portal. A nutraceutical brand in Andheri goes D2C with a store. The timeline below shows how the middle case typically runs.

A Mumbai team that already works with regulated cargo

Fair question: what does a web team know about how pharma works? Honest answer: we don't run your compliance, and we never claim to. But we do build for a Mumbai fulfilment company that handles pharmaceutical and hazardous cargo, so we've seen up close how this industry moves. Documentation first. No shortcuts. Every batch accounted for. We build websites and portals the same way: scoped in writing, fixed quotes, your sign-off at every gate.

The rest is track record. Nipralo has been building software since 2011 from our office in Ghatkopar East. 1000+ clients. Zero abandoned projects. We work across the belt: Chakala and MIDC Andheri offices we can reach within the hour, and Taloja, Boisar and Tarapur MIDC units we serve over calls, screen shares and site visits when scoping needs them. Some of our Andheri work is on the web development in Andheri page if you want a feel for how we handle that market.

If you're weighing a rebuild, don't overthink the first step. Send the product list, or just tell us what you make. The buttons below reach a real person.